IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: Potential relevance to psoriasis

Journal of Investigative Dermatology

Volumn 133, Issue 12, 2013, Pages 2741-2752

  Wang, Claire Q F ^a   Akalu, Yemsratch T ^a   Suarez Farinas, Mayte ^a   Gonzalez, Juana ^a   Mitsui, Hiroshi ^a   Lowes, Michelle A ^a   Orlow, Seth J ^b   Manga, Prashiela ^b   Krueger, James G ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 3; CXCL1 CHEMOKINE; INTERLEUKIN 17; INTERLEUKIN 8; MELANOCORTIN 1 RECEPTOR; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

ARTICLE; CELL COUNT; CONTROLLED STUDY; DERMATITIS; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; MELANOCYTE; MELANOGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSORIASIS;

EID: 84887822783     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.237     Document Type: Article

References (58)

1. Baxter LL, Loftus SK, PaVan WJ (2009) Networks and pathways in pigmentation, health, and disease. Wiley Interdiscip Rev Syst Biol Med 1:359-71
2. Beaumont KA, Smit DJ, Liu YY et al. (2012) Melanocortin-1 receptor-mediated signalling pathways activated by NDP-MSH and HBD3 ligands. Pigment Cell Melanoma Res 25:370-4
3. Brenner M, Hearing VJ (2008) Modifying skin pigmentation-approaches through intrinsic biochemistry and exogenous agents. Drug Discov Today Dis Mech 5:e189-99
4. Burge SM, Bristol M, Millard PR et al. (1986) Pigment changes in human skin after cryotherapy. Cryobiology 23:422-32
5. Chamian F, Lowes MA, Lin SL et al. (2005) Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci USA 102:2075-80
6. Chiricozzi A, Guttman-Yassky E, Suarez-Farinas M et al. (2011) Integrative responses to IL-17 and TNF-a in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 131: 677-87
7. Crawford S, Belajic D, Wei J et al. (2008) A novel B-RAF inhibitor blocks interleukin-8 (IL-8) synthesis in human melanoma xenografts, revealing IL-8 as a potential pharmacodynamic biomarker. Mol Cancer Ther 7:492-9
8. Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339-50
9. Fuentes-Duculan J, Suarez-Farinas M, Zaba LC et al. (2010) A subpopulation of CD163-positive macrophages is classically activated in psoriasis. J Invest Dermatol 130:2412-22
10. Gottlieb AB, Chamian F, Masud S et al. (2005) TNF inhibition rapidly downregulates multiple proinflammatory pathways in psoriasis plaques. J Immunol 175:2721-9
11. Guilloteau K, Paris I, Pedretti N et al. (2010) Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1a, and TNFa recapitulates some features of psoriasis. J Immunol 184:5263-70
12. Haghnegahdar H, Du J, Wang D et al. (2000) The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J Leukoc Biol 67:53-62
13. Harder J, Bartels J, Christophers E et al. (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707-13
14. Harder J, Dressel S, Wittersheim M et al. (2010) Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 130:1355-64
15. Hartupee J, Liu C, Novotny M et al. (2007) IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 179:4135-41
16. Hollox EJ, Huffmeier U, Zeeuwen PL et al. (2008) Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40:23-5
17. Iyoda M, Shibata T, Kawaguchi M et al. (2010) IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta. Am J Physiol Renal Physiol 298:F779-87
18. Koenders MI, Marijnissen RJ, Devesa I et al. (2011) Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1beta, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis. Arthritis Rheum 63:2329-39
19. Kotobuki Y, Tanemura A, Yang L et al. (2012) Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris. Pigment Cell Melanoma Res 25:219-30
20. Krueger JG, Fretzin S, Suarez-Farinas M et al. (2012) IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J Allergy Clin Immunol 130:145-154 e149
21. Kryczek I, Wei S, Szeliga W et al. (2009) Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 114:357-9
22. Leonardi C, Matheson R, Zachariae C et al. (2012) Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 366:1190-9
23. Levy C, Khaled M, Fisher DE (2006) MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12:406-14
24. Liang SC, Tan XY, Luxenberg DP et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271-9
25. Manga P, Orlow SJ (2001) Inverse correlation between pink-eyed dilution protein expression and induction of melanogenesis by bafilomycin A1. Pigment Cell Res 14:362-7
26. Martin-Orozco N, Muranski P, Chung Y et al. (2009) T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31:787-98
27. Martinez-Esparza M, Ferrer C, Castells MT et al. (2001) Transforming growth factorb1 mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation. Int J Biochem Cell Biol 33:971-83
28. Martinez-Esparza M, Solano F, Garcia-Borron JC (1999) Independent regulation of tyrosinase by the hypopigmenting cytokines TGFb1 and TNFa and the melanogenic hormone aMSH in B16 mouse melanocytes. Cell Mol Biol (Noisy-le-grand) 45:991-1000
29. Mockenhaupt M, Peters F, Schwenk-Davoine I et al. (2003) Evidence of involvement of CXC-chemokines in proliferation of cultivated human melanocytes. Int J Mol Med 12:597-601
30. Muranski P, Boni A, Antony PA et al. (2008) Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112:362-73
31. Nograles KE, Zaba LC, Guttman-Yassky E et al. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159:1092-102
32. Nomura I, Goleva E, Howell MD et al. (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262-9
33. Nonaka M, Ogihara N, Fukumoto A et al. (2009) Synergistic induction of macrophage inflammatory protein-3alpha;/CCL20 production by interleukin-17A and tumor necrosis factor-alpha; in nasal polyp fibroblasts. World Allergy Organ J 2:218-23
34. Norgauer J, Dichmann S, Peters F et al. (2003) Tumor necrosis factor alpha induces upregulation of CXC-chemokine receptor type II expression and magnifies the proliferative activity of CXC-chemokines in human melanocytes. Eur J Dermatol 13:124-9
35. Papp KA, Leonardi C, Menter A et al. (2012) Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 366:1181-9
36. Peric M, Koglin S, Dombrowski Y et al. (2009) Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis. PLoS One 4:e6340
37. Rees JL, Harding RM (2012) Understanding the evolution of human pigmentation: recent contributions from population genetics. J Invest Dermatol 132:846-53
38. Schadendorf D, Moller A, Algermissen B et al. (1993) IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 151:2667-75
39. Scheibenbogen C, Mohler T, Haefele J et al. (1995) Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load. Melanoma Res 5:179-81
40. Shen F, Gaffen SL (2008) Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 41:92-104
41. Shen F, Hu Z, Goswami J et al. (2006) Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem 281:24138-48
42. Singh RK, Gutman M, Radinsky R et al. (1994) Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 54:3242-7
43. Singh RK, Varney ML (2000) IL-8 expression in malignant melanoma: implications in growth and metastasis. Histol Histopathol 15:843-9
44. Sturm RA (2009) Molecular genetics of human pigmentation diversity. Hum Mol Genet 18:R9-17
45. Swope VB, Abdel-Malek Z, Kassem LM et al. (1991) Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 96:180-5
46. Swope VB, Jameson JA, McFarland KL et al. (2012) Defining MC1R regulation in human melanocytes by its agonist amelanocortin and antagonists agouti signaling protein and b-defensin 3. J Invest Dermatol 132:2255-62
47. Taylor S, Grimes P, Lim J et al. (2009) Postinflammatory hyperpigmentation. J Cutan Med Surg 13:183-91
48. Tian S, Krueger JG, Li K et al. (2012) Meta-analysis derived (MAD) transcriptome of psoriasis defines the core pathogenesis of disease. PLoS One 7:e44274
49. Tomita Y, Maeda K, Tagami H (1989) Mechanisms for hyperpigmentation in postinflammatory pigmentation, urticaria pigmentosa and sunburn. Dermatologica 179(Suppl 1):49-53
50. Toosi S, Orlow SJ, Manga P (2012) Vitiligo inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. J Invest Dermatol 132:2601-9
51. Vachiramon V, Thadanipon K (2011) Postinflammatory hypopigmentation. Clin Exp Dermatol 36:708-14
52. Venner TJ, Sauder DN, Feliciani C et al. (1995) Interleukin-8 and melanoma growth-stimulating activity (GRO) are induced by ultraviolet B radiation in human keratinocyte cell lines. Exp Dermatol 4:138-45
53. Wang CQ, Cruz-Inigo AE, Fuentes-Duculan J et al. (2011) Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS One 6:e18907
54. Wang D, Yang W, Du J et al. (2000) MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression. Oncogene 19:4647-59
55. Yang G, Li Y, Nishimura EK et al. (2008) Inhibition of PAX3 by TGF-b modulates melanocyte viability. Mol Cell 32:554-63
56. Zaba LC, Cardinale I, Gilleaudeau P et al. (2007) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204:3183-94
57. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ et al. (2010) Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis. J Allergy Clin Immunol 125:1261-1269
58. Zaba LC, Suarez-Farinas M, Fuentes-Duculan J et al. (2009) Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol 124:1022-10 e1-395